BioSpace News Archive

According to Vision Research Reports, the endoscopy devices market size is expected to reach around US$ 72.9 billion by 2030 and is projected to grow at a remarkable CAGR of 9.3% from 2021 to 2030.

The global pharmacovigilance market is registering growth at a CAGR of 10.6% during the forecast period 2022 to 2030 and to reach valuation USD 18.36 billion by 2030, according to Vision Research Reports.

Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on June 1, 2022 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in May 2022.

Paratek Pharmaceuticals, Inc. announced that Evan Loh, M.D., chief executive officer, will participate in a fireside chat June 9 from 3:30 to 3:55 p.m. Eastern Time at the Jefferies Healthcare Conference in New York City.

According to Vision Research Reports, the RNA analysis market is expected to garner growth at a CAGR of 14.44% during forecast period 2021 to 2030 and to reach around US$ 30.48 billion by 2030.

Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer and other serious diseases, announced that President and Chief Executive Officer Norbert Bischofberger, Ph.D., will participate in fireside chats at the following investor conferences:

Cytokinetics, Incorporated announced that on May 31, 2022 it granted stock options to purchase an aggregate of 179,100 shares of common stock to 23 new employees, whose employment commenced in May 2022, as a material inducement to their employment.

Ultragenyx Pharmaceutical Inc. announced that Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer and President, will present at the Jefferies Global Healthcare Conference on Wednesday, June 8, 2022, at 2:30 PM ET in New York.

Cytek® Biosciences, Inc. announced that it will host its inaugural Analyst and Investor Day on Wednesday June 22, with presentations beginning at 9:00 a.m. ET.

Longboard Pharmaceuticals, Inc. announced that members of its leadership team will participate in five upcoming events being hosted by respected epilepsy-focused patient advocacy groups.